Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR50721
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Weber, Daniel; Reddy, U Venkateswara; Wang, Songlin; Larsen, Erik; Gopinath, Tata; Gustavsson, Martin; Cornea, Razvan; Thomas, David; De Simone, Alfonso; Veglia, Gianluigi. "Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca 2+ and phosphorylation" Elife 10, e66226-e66226 (2021).
PubMed: 33978571
Assembly members:
entity_1, polymer, 53 residues, 6166 Da.
entity_2, polymer, 1001 residues, Formula weight is not available
entity_CA, non-polymer, 40.078 Da.
Natural source: Common Name: rabbit Taxonomy ID: 9986 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Oryctolagus cuniculus
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pMal-c2x
Entity Sequences (FASTA):
entity_1: AMEKVQYLTRSAIRRASTIE
MPQQARQNLQNLFINFALIL
IFLLLIAIIVMLL
entity_2: MEAAHSKSTEECLAYFGVSE
TTGLTPDQVKRHLEKYGHNE
LPAEEGKSLWELVIEQFEDL
LVRILLLAACISFVLAWFEE
GEETITAFVEPFVILLILIA
NAIVGVWQERNAENAIEALK
EYEPEMGKVYRADRKSVQRI
KARDIVPGDIVEVAVGDKVP
ADIRILSIKSTTLRVDQSIL
TGESVSVIKHTEPVPDPRAV
NQDKKNMLFSGTNIAAGKAL
GIVATTGVSTEIGKIRDQMA
ATEQDKTPLQQKLDEFGEQL
SKVISLICVAVWLINIGHFN
DPVHGGSWIRGAIYYFKIAV
ALAVAAIPEGLPAVITTCLA
LGTRRMAKKNAIVRSLPSVE
TLGCTSVICSDKTGTLTTNQ
MSVCKMFIIDKVDGDFCSLN
EFSITGSTYAPEGEVLKNDK
PIRSGQFDGLVELATICALC
NDSSLDFNETKGVYEKVGEA
TETALTTLVEKMNVFNTEVR
NLSKVERANACNSVIRQLMK
KEFTLEFSRDRKSMSVYCSP
AKSSRAAVGNKMFVKGAPEG
VIDRCNYVRVGTTRVPMTGP
VKEKILSVIKEWGTGRDTLR
CLALATRDTPPKREEMVLDD
SSRFMEYETDLTFVGVVGML
DPPRKEVMGSIQLCRDAGIR
VIMITGDNKGTAIAICRRIG
IFGENEEVADRAYTGREFDD
LPLAEQREACRRACCFARVE
PSHKSKIVEYLQSYDEITAM
TGDGVNDAPALKKAEIGIAM
GSGTAVAKTASEMVLADDNF
STIVAAVEEGRAIYNNMKQF
IRYLISSNVGEVVCIFLTAA
LGLPEALIPVQLLWVNLVTD
GLPATALGFNPPDLDIMDRP
PRSPKEPLISGWLFFRYMAI
GGYVGAATVGAAAWWFMYAE
DGPGVTYHQLTHFMQCTEDH
PHFEGLDCEIFEAPEPMTMA
LSVLVTIEMCNALNSLSENQ
SLMRMPPWVNIWLLGSICLS
MSLHFLILYVDPLPMIFKLK
ALDLTQWLMVLKISLPVIGL
DEILKFIARNYLEDPEDERR
K
Data type | Count |
15N chemical shifts | 10 |
dipolar coupling values | 10 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | PLN | 1 |
2 | SERCA | 2 |
3 | CA, ion | 3 |
Entity 1, PLN 53 residues - 6166 Da.
Monomeric cysteine-null mutant (C36A/C41F/C46A). N-terminal Ala0 left over from cleavage of MBP fusion protein.
1 | ALA | MET | GLU | LYS | VAL | GLN | TYR | LEU | THR | ARG | ||||
2 | SER | ALA | ILE | ARG | ARG | ALA | SER | THR | ILE | GLU | ||||
3 | MET | PRO | GLN | GLN | ALA | ARG | GLN | ASN | LEU | GLN | ||||
4 | ASN | LEU | PHE | ILE | ASN | PHE | ALA | LEU | ILE | LEU | ||||
5 | ILE | PHE | LEU | LEU | LEU | ILE | ALA | ILE | ILE | VAL | ||||
6 | MET | LEU | LEU |
Entity 2, SERCA 1001 residues - Formula weight is not available
1 | MET | GLU | ALA | ALA | HIS | SER | LYS | SER | THR | GLU | ||||
2 | GLU | CYS | LEU | ALA | TYR | PHE | GLY | VAL | SER | GLU | ||||
3 | THR | THR | GLY | LEU | THR | PRO | ASP | GLN | VAL | LYS | ||||
4 | ARG | HIS | LEU | GLU | LYS | TYR | GLY | HIS | ASN | GLU | ||||
5 | LEU | PRO | ALA | GLU | GLU | GLY | LYS | SER | LEU | TRP | ||||
6 | GLU | LEU | VAL | ILE | GLU | GLN | PHE | GLU | ASP | LEU | ||||
7 | LEU | VAL | ARG | ILE | LEU | LEU | LEU | ALA | ALA | CYS | ||||
8 | ILE | SER | PHE | VAL | LEU | ALA | TRP | PHE | GLU | GLU | ||||
9 | GLY | GLU | GLU | THR | ILE | THR | ALA | PHE | VAL | GLU | ||||
10 | PRO | PHE | VAL | ILE | LEU | LEU | ILE | LEU | ILE | ALA | ||||
11 | ASN | ALA | ILE | VAL | GLY | VAL | TRP | GLN | GLU | ARG | ||||
12 | ASN | ALA | GLU | ASN | ALA | ILE | GLU | ALA | LEU | LYS | ||||
13 | GLU | TYR | GLU | PRO | GLU | MET | GLY | LYS | VAL | TYR | ||||
14 | ARG | ALA | ASP | ARG | LYS | SER | VAL | GLN | ARG | ILE | ||||
15 | LYS | ALA | ARG | ASP | ILE | VAL | PRO | GLY | ASP | ILE | ||||
16 | VAL | GLU | VAL | ALA | VAL | GLY | ASP | LYS | VAL | PRO | ||||
17 | ALA | ASP | ILE | ARG | ILE | LEU | SER | ILE | LYS | SER | ||||
18 | THR | THR | LEU | ARG | VAL | ASP | GLN | SER | ILE | LEU | ||||
19 | THR | GLY | GLU | SER | VAL | SER | VAL | ILE | LYS | HIS | ||||
20 | THR | GLU | PRO | VAL | PRO | ASP | PRO | ARG | ALA | VAL | ||||
21 | ASN | GLN | ASP | LYS | LYS | ASN | MET | LEU | PHE | SER | ||||
22 | GLY | THR | ASN | ILE | ALA | ALA | GLY | LYS | ALA | LEU | ||||
23 | GLY | ILE | VAL | ALA | THR | THR | GLY | VAL | SER | THR | ||||
24 | GLU | ILE | GLY | LYS | ILE | ARG | ASP | GLN | MET | ALA | ||||
25 | ALA | THR | GLU | GLN | ASP | LYS | THR | PRO | LEU | GLN | ||||
26 | GLN | LYS | LEU | ASP | GLU | PHE | GLY | GLU | GLN | LEU | ||||
27 | SER | LYS | VAL | ILE | SER | LEU | ILE | CYS | VAL | ALA | ||||
28 | VAL | TRP | LEU | ILE | ASN | ILE | GLY | HIS | PHE | ASN | ||||
29 | ASP | PRO | VAL | HIS | GLY | GLY | SER | TRP | ILE | ARG | ||||
30 | GLY | ALA | ILE | TYR | TYR | PHE | LYS | ILE | ALA | VAL | ||||
31 | ALA | LEU | ALA | VAL | ALA | ALA | ILE | PRO | GLU | GLY | ||||
32 | LEU | PRO | ALA | VAL | ILE | THR | THR | CYS | LEU | ALA | ||||
33 | LEU | GLY | THR | ARG | ARG | MET | ALA | LYS | LYS | ASN | ||||
34 | ALA | ILE | VAL | ARG | SER | LEU | PRO | SER | VAL | GLU | ||||
35 | THR | LEU | GLY | CYS | THR | SER | VAL | ILE | CYS | SER | ||||
36 | ASP | LYS | THR | GLY | THR | LEU | THR | THR | ASN | GLN | ||||
37 | MET | SER | VAL | CYS | LYS | MET | PHE | ILE | ILE | ASP | ||||
38 | LYS | VAL | ASP | GLY | ASP | PHE | CYS | SER | LEU | ASN | ||||
39 | GLU | PHE | SER | ILE | THR | GLY | SER | THR | TYR | ALA | ||||
40 | PRO | GLU | GLY | GLU | VAL | LEU | LYS | ASN | ASP | LYS | ||||
41 | PRO | ILE | ARG | SER | GLY | GLN | PHE | ASP | GLY | LEU | ||||
42 | VAL | GLU | LEU | ALA | THR | ILE | CYS | ALA | LEU | CYS | ||||
43 | ASN | ASP | SER | SER | LEU | ASP | PHE | ASN | GLU | THR | ||||
44 | LYS | GLY | VAL | TYR | GLU | LYS | VAL | GLY | GLU | ALA | ||||
45 | THR | GLU | THR | ALA | LEU | THR | THR | LEU | VAL | GLU | ||||
46 | LYS | MET | ASN | VAL | PHE | ASN | THR | GLU | VAL | ARG | ||||
47 | ASN | LEU | SER | LYS | VAL | GLU | ARG | ALA | ASN | ALA | ||||
48 | CYS | ASN | SER | VAL | ILE | ARG | GLN | LEU | MET | LYS | ||||
49 | LYS | GLU | PHE | THR | LEU | GLU | PHE | SER | ARG | ASP | ||||
50 | ARG | LYS | SER | MET | SER | VAL | TYR | CYS | SER | PRO | ||||
51 | ALA | LYS | SER | SER | ARG | ALA | ALA | VAL | GLY | ASN | ||||
52 | LYS | MET | PHE | VAL | LYS | GLY | ALA | PRO | GLU | GLY | ||||
53 | VAL | ILE | ASP | ARG | CYS | ASN | TYR | VAL | ARG | VAL | ||||
54 | GLY | THR | THR | ARG | VAL | PRO | MET | THR | GLY | PRO | ||||
55 | VAL | LYS | GLU | LYS | ILE | LEU | SER | VAL | ILE | LYS | ||||
56 | GLU | TRP | GLY | THR | GLY | ARG | ASP | THR | LEU | ARG | ||||
57 | CYS | LEU | ALA | LEU | ALA | THR | ARG | ASP | THR | PRO | ||||
58 | PRO | LYS | ARG | GLU | GLU | MET | VAL | LEU | ASP | ASP | ||||
59 | SER | SER | ARG | PHE | MET | GLU | TYR | GLU | THR | ASP | ||||
60 | LEU | THR | PHE | VAL | GLY | VAL | VAL | GLY | MET | LEU | ||||
61 | ASP | PRO | PRO | ARG | LYS | GLU | VAL | MET | GLY | SER | ||||
62 | ILE | GLN | LEU | CYS | ARG | ASP | ALA | GLY | ILE | ARG | ||||
63 | VAL | ILE | MET | ILE | THR | GLY | ASP | ASN | LYS | GLY | ||||
64 | THR | ALA | ILE | ALA | ILE | CYS | ARG | ARG | ILE | GLY | ||||
65 | ILE | PHE | GLY | GLU | ASN | GLU | GLU | VAL | ALA | ASP | ||||
66 | ARG | ALA | TYR | THR | GLY | ARG | GLU | PHE | ASP | ASP | ||||
67 | LEU | PRO | LEU | ALA | GLU | GLN | ARG | GLU | ALA | CYS | ||||
68 | ARG | ARG | ALA | CYS | CYS | PHE | ALA | ARG | VAL | GLU | ||||
69 | PRO | SER | HIS | LYS | SER | LYS | ILE | VAL | GLU | TYR | ||||
70 | LEU | GLN | SER | TYR | ASP | GLU | ILE | THR | ALA | MET | ||||
71 | THR | GLY | ASP | GLY | VAL | ASN | ASP | ALA | PRO | ALA | ||||
72 | LEU | LYS | LYS | ALA | GLU | ILE | GLY | ILE | ALA | MET | ||||
73 | GLY | SER | GLY | THR | ALA | VAL | ALA | LYS | THR | ALA | ||||
74 | SER | GLU | MET | VAL | LEU | ALA | ASP | ASP | ASN | PHE | ||||
75 | SER | THR | ILE | VAL | ALA | ALA | VAL | GLU | GLU | GLY | ||||
76 | ARG | ALA | ILE | TYR | ASN | ASN | MET | LYS | GLN | PHE | ||||
77 | ILE | ARG | TYR | LEU | ILE | SER | SER | ASN | VAL | GLY | ||||
78 | GLU | VAL | VAL | CYS | ILE | PHE | LEU | THR | ALA | ALA | ||||
79 | LEU | GLY | LEU | PRO | GLU | ALA | LEU | ILE | PRO | VAL | ||||
80 | GLN | LEU | LEU | TRP | VAL | ASN | LEU | VAL | THR | ASP | ||||
81 | GLY | LEU | PRO | ALA | THR | ALA | LEU | GLY | PHE | ASN | ||||
82 | PRO | PRO | ASP | LEU | ASP | ILE | MET | ASP | ARG | PRO | ||||
83 | PRO | ARG | SER | PRO | LYS | GLU | PRO | LEU | ILE | SER | ||||
84 | GLY | TRP | LEU | PHE | PHE | ARG | TYR | MET | ALA | ILE | ||||
85 | GLY | GLY | TYR | VAL | GLY | ALA | ALA | THR | VAL | GLY | ||||
86 | ALA | ALA | ALA | TRP | TRP | PHE | MET | TYR | ALA | GLU | ||||
87 | ASP | GLY | PRO | GLY | VAL | THR | TYR | HIS | GLN | LEU | ||||
88 | THR | HIS | PHE | MET | GLN | CYS | THR | GLU | ASP | HIS | ||||
89 | PRO | HIS | PHE | GLU | GLY | LEU | ASP | CYS | GLU | ILE | ||||
90 | PHE | GLU | ALA | PRO | GLU | PRO | MET | THR | MET | ALA | ||||
91 | LEU | SER | VAL | LEU | VAL | THR | ILE | GLU | MET | CYS | ||||
92 | ASN | ALA | LEU | ASN | SER | LEU | SER | GLU | ASN | GLN | ||||
93 | SER | LEU | MET | ARG | MET | PRO | PRO | TRP | VAL | ASN | ||||
94 | ILE | TRP | LEU | LEU | GLY | SER | ILE | CYS | LEU | SER | ||||
95 | MET | SER | LEU | HIS | PHE | LEU | ILE | LEU | TYR | VAL | ||||
96 | ASP | PRO | LEU | PRO | MET | ILE | PHE | LYS | LEU | LYS | ||||
97 | ALA | LEU | ASP | LEU | THR | GLN | TRP | LEU | MET | VAL | ||||
98 | LEU | LYS | ILE | SER | LEU | PRO | VAL | ILE | GLY | LEU | ||||
99 | ASP | GLU | ILE | LEU | LYS | PHE | ILE | ALA | ARG | ASN | ||||
100 | TYR | LEU | GLU | ASP | PRO | GLU | ASP | GLU | ARG | ARG | ||||
101 | LYS |
Entity 3, CA, ion - Ca - 40.078 Da.
1 | CA |
sample_1: Phospholamban (PLN-AFA), [U-15N], 0.21 mM; HEPES 20 mM; potassium chloride 100 mM; sodium azide 1 mM; glycerol 2.5%; 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) 340 mM; 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC) 85 mM; 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) 106 mM; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid (PE-DTPA) 6.4 mM; Ytterbium(III) chloride 5 mM; Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1a) 0.23 mM; DTT 2 mM; magnesium chloride 5 mM; calcium Chloride 5 mM
sample_conditions_1: pH: 7; pressure: 1 atm; temperature: 298.15 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D NH SLF | sample_1 | anisotropic | sample_conditions_1 |
NMRPipe - processing
VNMRj - collection
NMRFAM-SPARKY - data analysis